FDA Inspection
Mark L. Brantly, M.D.Mark L. Brantly, M.D. – FDA Inspection, Dec 11, 2009
Record Details
This FDA Inspection record concerns Mark L. Brantly, M.D., with an inspection on December 11, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Mark L. Brantly, M.D.
- Inspection Date
- December 11, 2009
- Product Type
- Biologics
View Company Profile
ID · 61fc5414-e3ba-4dd2-abd8-8054352acb10
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 634715
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mark L. Brantly, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 14, 2017 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| September 21, 2009 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Mark L. Brantly, M.D.
- FDA Inspection 1012256 - 2017-04-14
- FDA Inspection 621495 - 2009-09-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.